Skip to main
GRAL
GRAL logo

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc has seen a significant appreciation in its stock, with shares rising nearly 90% in the past month, indicating strong investor confidence. The company's positive outlook is supported by key developments, including encouraging data from the PATHFINDER 2 trial, a favorable proprietary Total Addressable Market (TAM) analysis revealing substantial opportunities in the US and UK, and established partnerships aimed at capitalizing on this potential. Additionally, GRAIL's financial position has been bolstered by over $400 million in pending funding, underscoring its strong market position in multi-cancer early detection technologies despite certain regulatory uncertainties.

Bears say

GRAIL Inc has sustained significant net losses since its inception and projects continued losses as it navigates regulatory challenges and expands its operational capacity. The company faces multiple risks, including legislative delays impacting reimbursement for its multi-cancer early detection tests, adoption barriers for its novel product, and intense competition from established diagnostics companies that possess greater resources. Additionally, rising selling, general, and administrative expenses, along with potential delays in clinical study results, pose substantial hurdles that could impede GRAIL's ability to successfully commercialize its offerings.

GRAIL Inc (GRAL) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 3 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.